JODY DUBE: Open Payments
NPI 1275706244 · NORTH ATTLEBORO, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,708 in 135 payments from 19 companies in 2025. Trend: 2023 $3,021 · 2024 $2,716 · 2025 $2,708
Food & beverage: $2,708
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 30 | $634 |
| ABBVIE INC. | 33 | $460 |
| LEO Pharma Inc. | 14 | $363 |
| Amgen Inc. | 8 | $154 |
| UCB, Inc. | 7 | $152 |
| Regeneron Healthcare Solutions, Inc. | 4 | $113 |
| GENZYME CORPORATION | 4 | $106 |
| Janssen Biotech, Inc. | 4 | $106 |
| PFIZER INC. | 4 | $103 |
| E.R. Squibb & Sons, L.L.C. | 6 | $101 |
Products named: COSENTYX, SKYRIZI, ADBRY, DUPIXENT, OTEZLA, Bimzelx, RINVOQ, TREMFYA.
Industry payments across MA — which companies pay providers there.
